Ieuan Hughes

Last updated
Ieuan Hughes
Professor of Paediatrics, University of Cambridge
In office
1989–2011
Personal details
Born
Ieuan Arwel Hughes

(1944-11-09) 9 November 1944 (age 80)

Ieuan Arwel Hughes (born 9 November 1944) is a British paediatric endocrinologist who is an emeritus professor of paediatrics at the University of Cambridge. Hughes is most notable for long-standing research into disorders of sex development (DSD), established one of the largest and most comprehensive databases of cases of DSD including publishing the Consensus on DSD management framework which, barely eight years after its publication, is now already accepted worldwide as the framework for care of patients and families with DSD. [1]

Contents

Career

Hughes was a professor of paediatrics at the University of Cambridge, and the head of the School of Clinical Medicine's Department of Paediatrics for 23 years before retiring as an emeritus professor. Throughout his career in paediatric endocrinology, he specialised in disorders of sex development (DSD); he created a comprehensive database of DSD cases and established international consensus-based guidelines for the management of these cases. He also founded and chaired the Clinical Committee of the British Society for Paediatric Endocrinology and Diabetes and published over 230 original journal articles. [1]

Societies

Awards and honours

Selected bibliography

Related Research Articles

<span class="mw-page-title-main">5α-Reductase 2 deficiency</span> Medical condition

5α-Reductase 2 deficiency (5αR2D) is an autosomal recessive condition caused by a mutation in SRD5A2, a gene encoding the enzyme 5α-reductase type 2 (5αR2). The condition is rare, affects only genetic males, and has a broad spectrum.

Sex assignment is the discernment of an infant's sex, typically made at birth based on an examination of the baby's external genitalia by a healthcare provider such as a midwife, nurse, or physician. In the vast majority of cases (99.95%), sex is assigned unambiguously at birth. However, in about 1 in 2000 births, the baby's genitalia may not clearly indicate male or female, necessitating additional diagnostic steps, and deferring sex assignment.

<span class="mw-page-title-main">Intersex medical interventions</span> Performed to modify atypical or ambiguous genitalia

Intersex medical interventions (IMI), sometimes known as intersex genital mutilations (IGM), are surgical, hormonal and other medical interventions performed to modify atypical or ambiguous genitalia and other sex characteristics, primarily for the purposes of making a person's appearance more typical and to reduce the likelihood of future problems. The history of intersex surgery has been characterized by controversy due to reports that surgery can compromise sexual function and sensation, and create lifelong health issues. The medical interventions can be for a variety of reasons, due to the enormous variety of the disorders of sex development. Some disorders, such as salt-wasting disorder, can be life-threatening if left untreated.

<span class="mw-page-title-main">History of intersex surgery</span>

The history of intersex surgery is intertwined with the development of the specialities of pediatric surgery, pediatric urology, and pediatric endocrinology, with our increasingly refined understanding of sexual differentiation, with the development of political advocacy groups united by a human qualified analysis, and in the last decade by doubts as to efficacy, and controversy over when and even whether some procedures should be performed.

Pediatric endocrinology is a medical subspecialty dealing with disorders of the endocrine glands, such as variations of physical growth and sexual development in childhood, diabetes and many more.

<span class="mw-page-title-main">Hyperandrogenism</span> Excess androgens (male-related hormones) in the body

Hyperandrogenism is a medical condition characterized by high levels of androgens. It is more common in women than men. Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation. Complications may include high blood cholesterol and diabetes. It occurs in approximately 5% of women of reproductive age.

Polymenorrhea, also known as frequent periods, frequent menstruation, or frequent menstrual bleeding, is a menstrual disorder in which menstrual cycles are shorter than 21 days in length and hence where menstruation occurs more frequently than usual. Cycles are regular and menstrual flow is normal in the condition. Normally, menstrual cycles are 25 to 30 days in length, with a median duration of 28 days.

Ovotesticular syndrome is a rare congenital condition where an individual is born with both ovarian and testicular tissue. It is one of the rarest DSDs, with only 500 reported cases. Commonly, one or both gonads is an ovotestis containing both types of tissue. Although it is similar in some ways to mixed gonadal dysgenesis, the conditions can be distinguished histologically.

<span class="mw-page-title-main">Barbara Ansell</span> English physician (1923–2001)

Barbara Mary Ansell was a British medical doctor and the founder of the field of paediatric rheumatology. Ansell was notable for outstanding contributions to the advancement of paediatric knowledge, specifically defining chronic joint disorders and the improvement of their management.

Pseudohermaphroditism is an outdated term for when an individual's gonads were mismatched with their internal reproductive system and/or external genitalia. The term was contrasted with "true hermaphroditism", a condition describing an individual with both female and male reproductive gonadal tissues. Associated conditions includes Persistent Müllerian duct syndrome and forms of androgen insensitivity syndrome.

<span class="mw-page-title-main">Disorders of sex development</span> Medical conditions involving the development of the reproductive system

Disorders of sex development (DSDs), also known as differences in sex development or variations in sex characteristics (VSC), are congenital conditions affecting the reproductive system, in which development of chromosomal, gonadal, or anatomical sex is atypical. DSDs is a clinical term used in some medical settings for what are otherwise referred to as intersex traits. The term was first introduced in 2006 and has not been without controversy.

<span class="mw-page-title-main">Complete androgen insensitivity syndrome</span> Medical condition

Complete androgen insensitivity syndrome (CAIS) is an AIS condition that results in the complete inability of the cell to respond to androgens. As such, the insensitivity to androgens is only clinically significant when it occurs in individuals who are exposed to significant amounts of testosterone at some point in their lives. The unresponsiveness of the cell to the presence of androgenic hormones prevents the masculinization of male genitalia in the developing fetus, as well as the development of male secondary sexual characteristics at puberty, but does allow, without significant impairment, female genital and sexual development in those with the condition.

<span class="mw-page-title-main">Intersex</span> Atypical congenital variations of sex characteristics

Intersex people are individuals born with any of several sex characteristics, including chromosome patterns, gonads, or genitals that, according to the Office of the United Nations High Commissioner for Human Rights, "do not fit typical binary notions of male or female bodies".

<span class="mw-page-title-main">David Dunger</span> British paediatrician (died 2021)

David Dunger was a British paediatric endocrinologist and chair of paediatrics at the University of Cambridge. Dunger was most notable for research into three areas, pathogenesis of type 1 diabetes and its complications, perinatal origins of risk for obesity and type 2 diabetes along with experimental medicine.

<span class="mw-page-title-main">Eric Vilain</span> French-American physician-scientist

Eric Vilain is a physician-scientist and professor in the fields of differences of sex development (DSDs) and precision medicine. He is the Associate Vice Chancellor for Scientific Affairs at the University of California, Irvine Health Affairs and also the director of the UCI Institute for Clinical and Translational Science. He previously was the director of the Center for Genetic Medicine Research at Children's National Medical Center and the chair of the Department of Genomics and Precision Medicine at the George Washington University School of Medicine & Health Sciences in Washington, D.C. Vilain is a fellow of the American College of Medical Genetics, serves on the International Olympic Committee's Medical Commission, and sits on the Board of Scientific Counselors for the National Institute of Child Health and Human Development (NICHD).

Late onset congenital adrenal hyperplasia (LOCAH), also known as nonclassic congenital adrenal hyperplasia, is a milder form of congenital adrenal hyperplasia (CAH), a group of autosomal recessive disorders characterized by impaired cortisol synthesis that leads to variable degrees of postnatal androgen excess.

Syed Faisal Ahmed is British physician and academic who holds the Samson Gemmell Chair of Child Health at the University of Glasgow. Ahmed is an honorary consultant paediatric endocrinologist at the Royal Hospital for Children Glasgow. and was appointed to this post in 2012, being the seventh clinical academic to hold this endowed professorship which is the oldest chair of paediatrics in the United Kingdom.

<span class="mw-page-title-main">Richard H. R. White</span> British paediatric nephrologist

Richard Henry Reeve White was a paediatric nephrologist, emeritus Professor of Paediatric Nephrology from the University of Birmingham morphologist and archivist for British Association for Paediatric Nephrology.

<span class="mw-page-title-main">Intersex healthcare</span> Healthcare for intersex people throughout their lives

Intersex healthcare differs from the healthcare of endosex people due to the stigma towards and health needs of intersex people. Intersex healthcare is impacted by a history of concealing information from patients and medically unnecessary surgeries that continue to be performed. 1.7% of the general population is estimated to be intersex. Healthcare for intersex people can include treatments to improve the mental, cognitive, physical, and sexual health of intersex people. The need for and type of care can vary depending on one's intersex variation.

References

  1. 1 2 "Emeritus Professor Ieuan Hughes". Royal College of Paediatrics and Child Health. 28 February 2017. Retrieved 14 May 2017.
  2. "Professor Ieuan Hughes FMedSci FLSW". Academy of Medical Sciences. Archived from the original on 1 August 2016. Retrieved 14 May 2017.
  3. Wales, The Learned Society of. "Ieuan Hughes". The Learned Society of Wales. Retrieved 2023-08-30.
  4. "Professor Ieuan Hughes awarded James Spence 2014 Medal". School of Clinical Medicine, University of Cambridge. 13 January 2014. Retrieved 14 May 2017.